Evidence map›Paper›PMID 39866878›Full record

ArticleResearch square2025

Towards H&E Referenced Multiplex Immunofluorescence Interpretation: Spatial Co-localization, Cell Feature Validation, and Virtual H&E Generation.

Chen Wang, Jun Jiang, Raymond Moore, Brenna Novotny, Ruifeng Guo, Zachary Fogarty, Yuanhang Liu, Ellen Goode, Stacey Winham, Svetomir Markovic

Abstract readPreprint
In one paragraph

Article in Research square, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Chen WangMayo Clinic.ORCID 0000-0003-2638-3081
Jun JiangMayo Clinic.ORCID 0000-0003-1147-3666
Raymond MooreMayo Clinic.
Brenna NovotnyMayo Clinic.ORCID 0000-0003-4732-1736
Ruifeng GuoMayo Clinic.ORCID 0000-0003-3345-0502
Zachary FogartyMayo Clinic.ORCID 0000-0001-5588-3216
Yuanhang LiuMayo Clinic.
Ellen GoodeMayo Clinic.ORCID 0000-0002-9094-8326
Stacey WinhamMayo Clinic.ORCID 0000-0002-8492-9102
Svetomir MarkovicMayo Clinic.ORCID 0000-0002-9238-4325

Funding

Use of microfluidic tumor cultures to enable clinical trials of therapies for ovarian cancerP50CA136393 · NCI · MAYO CLINIC ROCHESTER · PI ELLEN L. GOODE · 2009 to 2026
$37.0M
Quantitative assessment of pre-metastatic immune subversion as a risk factor for melanoma relapseR01CA260259 · NCI · MAYO CLINIC ROCHESTER · PI MARKOVIC, SVETOMIR NENAD · 2022 to 2025
$3.0M
NCI NIH HHS P50 CA136393NCI NIH HHS R01 CA260259
6 · The paper itself

Abstract

Multiplexed Immunofluorescence (MxIF) enables detailed immune cell phenotyping, providing critical insights into cell behavior within the tumor immune microenvironment (TIME). However, signal integrity can be compromised due to the complex cyclic staining processes inherent to MxIF. Hematoxylin and Eosin (H&E) staining, on the other hand, offers complementary information through its depiction of cell morphology and texture patterns and is often visually cross-referenced with MxIF in clinical settings. In this study, we proposed a novel framework to align H&E and MxIF images for precise cross-modal cell feature validation. Using cell detection outputs from each modality as anchors, we formulated the multimodal image registration problem as point set alignment. Coherent Point Drift (CPD) is employed for initial alignment, followed by Graph Matching (GM) for refinement. Evaluations on ovarian cancer tissue microarrays (TMAs) demonstrate that our method achieves high alignment accuracy, enabling reliable validation of cell-level features across modalities for both restained and serial sections. Our results indicate that restained H&E enhances confidence in findings derived from MxIF. Additionally, we demonstrated the feasibility of generating high-quality virtual H&E images from MxIF data when restained H&E is unavailable, offering a viable alternative for integrated multimodal analysis.

Indexed as

Bioimage analysisHistopathology alignmentHistopathology registration

Identifiers

PMID39866878
PMCPMC11760245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.